Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Safety and Effectiveness in Treatment Management of Paroxysmal Atrial Fibrillation With the BWI Pulsed Field Ablation System With OMNYPULSE™ Catheter

NCT06455098 is registered in ClinicalTrials.gov with Biosense Webster, Inc. as lead sponsor.

NCT NCT06455098
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06455098 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Safety and Effectiveness in Treatment Management of Paroxysmal Atrial Fibrillation With the BWI Pulsed Field Ablation System With OMNYPULSE™ Catheter
Lead sponsor
Biosense Webster, Inc.
Phase
Not applicable
Overall status
Active, not recruiting
Start date
June 28, 2024
Completion date
July 31, 2027
Enrollment
354 (actual)
Sites
41

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation